Tivic Health Systems报告了一个巨大的损失,但看到股票上涨;其产品ClearUP在网上出售。 Tivic Health Systems reports a hefty loss but sees stock rise; its product, ClearUP, sold online.

Tivic保健系统是一家专门从事生物电子医学的保健技术公司,报告每季度每股损失19.68美元,财政指标为负值。 Tivic Health Systems, a health tech firm specializing in bioelectronic medicine, reported a quarterly loss of $19.68 per share, with negative financial metrics. 尽管有这些损失,其股票价格在星期五上涨了0.12美元,达到3.55美元。 Despite these losses, its stock price rose by $0.12 to $3.55 on Friday. 该公司的主要产品ClearUP是治疗鼻炎和鼻炎的一种疗法,通过直接对消费者的渠道和亚马逊和沃尔玛等在线平台出售。 The company's main product, ClearUP, a treatment for sinus and nasal inflammation, is sold through direct-to-consumer channels and online platforms like Amazon and Walmart.